ASP Isotopes Inc.ASPI
Materials · Materials · NASDAQ · United States · aspisotopes.com
ASP Isotopes develops and commercializes isotope enrichment technology, producing enriched isotopes for medical, semiconductor and nuclear energy applications, including silicon-28, ytterbium-176 and molybdenum-100, with a subsidiary pursuing enriched uranium for advanced reactors.
Key ratios
FCF / Sales
-270.9%TTM
2025
-198.9%2024
-677.3%2023
-1788.4%
ROA
-17.0%TTM
2025
-12.1%2024
-27.0%2023
-50.1%
ROE
-90.4%TTM
2025
-101.8%2024
-92.6%2023
-113.8%
Revenue growth
573.4%TTM
2025
475.5%2024
857.0%
Track ASPI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer